We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

CEVEC and VPM Sign Exclusive License Agreement

News   Jan 04, 2013

 
CEVEC and VPM Sign Exclusive License Agreement
 
 
Advertisement
 

RELATED ARTICLES

Accelerated Discovery of Bioactive Components in Seaweed

News

Using state-of-the-art approaches coupled with bio- and cheminformatics and machine learning, researchers at the GEOMAR Helmholtz Centre for Ocean Research Kiel have succeeded in discovering new, bioactive components of the Baltic Sea seaweed Fucus vesiculosus and its fungal symbiont against infectious bacteria or skin cancer.

READ MORE

Protective Antibodies for Rare, Polio-like Disease in Children Identified

News

Researchers have isolated human monoclonal antibodies that potentially can prevent a rare but devastating polio-like illness in children linked to a respiratory viral infection.

READ MORE

Mutated Form of SARS-CoV-2 Is Dominant, But Doesn't Make Patients Sicker, Study Says

News

In a collaborative research study, scientists show that a mutated version of SARS-CoV-2 has become the predominant form across the globe. Whilst the variant competes with the original strain, clinical data suggests that it does not make individuals sicker.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE